Table 1.
Percentage of amplified telomere molecules that contain C-type (TCAGGG) or G-type (TGAGGG) repeats.
| Cell line | Total molecules detected | % telomere molecules with C-type repeats (No. C-type + /total) | % telomere molecules with G-type repeats (No. G-type + /total) |
|---|---|---|---|
| XpYp telomere | |||
| HT1080 | 124 | 0 | 87 (108/124) |
| VA13/2RA | 254 | 76 (192/254) | 37 (93/254) |
| W-V | 237 | 47 (111/237) | 57 (134/237) |
| U2OS | 192 | 0 | 0 |
| SUSM-1 | 189 | 0 | 67 (126/189) |
| SAOS2 | 240 | 0 | 53 (128/240) |
| 12q telomere | |||
| HT1080 | 150 | 79 (119/150) | 72 (108/150) |
| VA13/2RA | 82 | 80 (66/82) | 0 |
| W-V | 115 | 33 (38/115) | 8 (9/115) |
| U2OS | 205 | 40 (83/205) | 51 (105/205) |
| SUSM-1 | 198 | 39 (78/198) | 40 (79/198) |
| SAOS2 | 85 | 34 (29/85) | 0 |
| 17p telomere | |||
| HT1080 | 77 | 0 | 0 |
| VA13/2RA | 125 | 90 (113/125) | 0 |
| W-V | 259 | 0 | 0 |
| U2OS | 95 | 74 (70/95) | 0 |
| SUSM-1 | 169 | 0 | 13 (22/169) |
| SAOS2 | 0 | 0 | 0 |